These success, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Issues.Disclaimer: The above mentioned is actually